Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazole-5-yl)-5-methyl-3(2h)-pyridazinone
2. Pimobendane
3. Ud Cg 115
4. Ud-cg 115
5. Ud-cg115
1. 74150-27-9
2. Pimobendane
3. Acardi
4. Dl-pimobendan
5. Vetmedin
6. D-pimobendan
7. (-)-pimobendan
8. Pimobendan, (-)-
9. (+)-pimobendan
10. Pimobendanum
11. Ud-cg 115 Bs
12. Ud-cg 115
13. 118428-37-8
14. Pimobendan, (+)-
15. Pimobendan (vetmedin)
16. Ud-cg-115bs
17. Racemic Pimobendan
18. 118428-38-9
19. Udcg-115
20. 6-(2-(4-methoxyphenyl)-1h-benzo[d]imidazol-5-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one
21. Ud-cg-115
22. 3-[2-(4-methoxyphenyl)-3h-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1h-pyridazin-6-one
23. Brn 4207330
24. 34ap3bbp9t
25. Chembl24646
26. 613jxv89su
27. 9htu209z0n
28. Chebi:32003
29. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-, (+)-
30. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-, (-)-
31. L-pimobendan
32. Racemic Pinobendan
33. 6-(2-(4-methoxyphenyl)-1h-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one
34. 6-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2h)-one
35. Pimobendan [inn-spanish]
36. Pimobendane [inn-french]
37. Pimobendanum [inn-latin]
38. (+)-ud-cg 115bs
39. (-)-ud-cg 115bs
40. Ncgc00274063-01
41. Unii-34ap3bbp9t
42. Unii-613jxv89su
43. Unii-9htu209z0n
44. Pimobendan [usan:inn:ban]
45. Ud-cg115
46. 3-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1h-pyridazin-6-one
47. Acardi (tn)
48. Pimobendan - Vetmedin
49. Pimobendan [mi]
50. Pimobendan [inn]
51. Pimobendan [jan]
52. Pimobendan [usan]
53. Pimobendan [mart.]
54. (+)-4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-3(2h)-pyridazinone
55. (-)-4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-3(2h)-pyridazinone
56. 4,5-dihydro-6-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-5-methyl-3(2h)-pyridazinone
57. 6-(2-(4-methoxyphenyl)-4,5-dihydro-1h-benzimidazol-5-yl)-5-methyl-3(2h)-pyridazinone
58. Pimobendan [usp-rs]
59. Pimobendan [who-dd]
60. Schembl27623
61. Mls006010188
62. Pimobendan (jan/usan/inn)
63. Pimobendan [green Book]
64. Dtxsid8048280
65. Pimobendan [ep Impurity]
66. Pimobendan, >=98% (hplc)
67. Hms3655i03
68. Hms3884c21
69. Kuc109647n
70. Pimobendan [usp Monograph]
71. Bcp02958
72. Hy-b0204
73. Ac-689
74. Bdbm50282617
75. Mfcd00761648
76. S1550
77. Akos015851937
78. Akos015967705
79. Ccg-267853
80. Db11450
81. Ks-1280
82. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-
83. 6-[2-(4-methoxy-phenyl)-1h-benzoimidazol-5-yl]-5-methyl-4,5-dihydro-2h-pyridazin-3-one
84. Ksc-210-009
85. Pimobendan [ema Epar Veterinary]
86. Fortekor Plus Component Pimobendan
87. Ncgc00274063-04
88. Ncgc00274063-05
89. 118428-36-7
90. Pimobendan 100 Microg/ml In Acetonitrile
91. Smr002530068
92. Bcp0726000255
93. Ft-0630830
94. P2779
95. Pimobendan Component Of Fortekor Plus
96. Sw219717-1
97. D01133
98. Ab01274800-01
99. Ab01274800_02
100. 150p279
101. Q414351
102. J-517984
103. Pimobendan, United States Pharmacopeia (usp) Reference Standard
104. 4,5-dihydro-6-[2-(4-methoxy-phenyl)-1h-benzimidazol-5-yl]-5-methyl-3 (2h)-pyridazinone
105. Pimobendan For System Suitability, European Pharmacopoeia (ep) Reference Standard
106. (+/-)-4,5-dihydro-6-(2-(p-methoxyphenyl)-5-benzimidazolyl)-5-methyl-3(2h)-pyridazinone
107. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-, (+/-)-
108. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-6-yl)-5-methyl-
Molecular Weight | 334.4 g/mol |
---|---|
Molecular Formula | C19H18N4O2 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 334.14297583 g/mol |
Monoisotopic Mass | 334.14297583 g/mol |
Topological Polar Surface Area | 79.4 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 530 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 100-07-2
End Use API : Pimobendan
About The Company : Shree Ganesh Remedies is established Since 1995 with an aim to manufacture, supply and export best quality of Pharmaceutical-intermediates, Bulk drugs and Speci...
Market Place
Reply
07 Oct 2022
Patents & EXCLUSIVITIES
Patent Expiration Date : 2026-11-08
Date Granted : 2016-05-03
Brand Name : VETMEDIN
Patent Number : 2629367
Filing Date : 2006-11-08
Strength per Unit : 1.25 mg
Dosage Form : CAPSULE
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2016-05-03
Patent Expiration Date : 2026-11-08
Date Granted : 2016-05-03
Brand Name : VETMEDIN
Patent Number : 2629367
Filing Date : 2006-11-08
Strength per Unit : 2.5 mg
Dosage Form : CAPSULE
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2016-05-03
Patent Expiration Date : 2026-11-08
Date Granted : 2016-05-03
Brand Name : VETMEDIN
Patent Number : 2629367
Filing Date : 2006-11-08
Strength per Unit : 5 mg
Dosage Form : CAPSULE
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2016-05-03
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?